Chromosomal instability and cytotoxicity induced by ribavirin: comparative analysis in cell lines with different drug-metabolizing profiles

References

• Allen, L.B., Huffman, J.H., and Sidwell, R.W., 1973. Failure of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (virazole, ICN 1229) to stimllate interferon. Antimicrobial Agents and Chemotherapy, 3, 534–535.
   PubMed Web of Science ®Google Scholar
• Becquemont, L., et al., 2002. Effect of interferon alpha-ribavirin bitherapy on cytochrome P450 1A2 and 2D6 and N-acetyltransferase-2 activities in patients with chronic active hepatitis C. Clinical Pharmacology and Therapeutics, 71 (6), 488–495.
   PubMed Web of Science ®Google Scholar
• Burgos, L., et al., 2014. Agents of earthy-musty taste and odor in water: evaluation of cytotoxicity, genotoxicity and toxicogenomics. The Science of the Total Environment, 490, 679–685.
   PubMed Web of Science ®Google Scholar
• Canonico, P.G., et al., 1984. Effects of ribavirin on red blood cells. Toxicology and Applied Pharmacology, 74 (2), 155–162.
   PubMed Web of Science ®Google Scholar
• de Kanter, C.T., et al., 2014. Viral hepatitis C therapy: pharmacokinetic and pharmacodynamic considerations. Clinical Pharmacokinetics, 53 (5), 409–427.
   PubMed Web of Science ®Google Scholar
• de Souza, A.P., Lehmann, M., and Dihl, R.R., 2017. Comparative study on the induction of complex genomic alterations after exposure of mammalian cells to carboplatin and oxaliplatin. Drug and Chemical Toxicology, 40 (4), 410–415.
   PubMed Web of Science ®Google Scholar
• Drechsel, D.N. and Kirschner, M.W., 1994. The minimum GTP cap required to stabilize microtubules. Current Biology, 4 (12), 1053–1061.
   PubMed Web of Science ®Google Scholar
• D’Souza, U.J. and Narayana, K., 2002. Mechanism of cytotoxicity of ribavirin in the rat bone marrow and testis. Indian Journal of Physiology Pharmacology, 46 (4), 468–474.
   PubMedGoogle Scholar
• Feld, J.J., et al., 2017. Ribavirin revisited in the era of direct-acting antiviral therapy for hepatitis C virus infection. Liver International, 37, 5–18.
   PubMed Web of Science ®Google Scholar
• Fenech, M., 2000. The in vitro micronucleus technique. Mutation Research, 455 (1–2), 81–95.
   PubMed Web of Science ®Google Scholar
• Fenech, M., 2006. Cytokinesis-block micronucleus assay evolves into a “cytome” assay of chromosomal instability, mitotic dysfunction and cell death. Mutation Research, 600 (1–2), 58–66.
   PubMed Web of Science ®Google Scholar
• Fenech, M., 2007. Cytokinesis-block micronucleus cytome assay. Nature Protocols, 2, 1084–1104.
   PubMed Web of Science ®Google Scholar
• Fukuchi, Y., et al., 2010. Characterization of ribavirin uptake systems in human hepatocytes. Journal of Hepatology, 52 (4), 486–492.
   PubMed Web of Science ®Google Scholar
• González-Grande, R., et al., 2016. New approaches in the treatment of hepatitis C. World Journal of Gastroenterology, 22 (4), 1421–1432.
   PubMed Web of Science ®Google Scholar
• Gower, E., et al., 2014. Global epidemiology and genotype distribution of the hepatitis C virus infection. Journal of Hepatology, 61, S45–S57.
   PubMed Web of Science ®Google Scholar
• Ilyin, G.P., et al., 1998. Ribavirin inhibits protein synthesis and cell proliferation induced by mitogenic factors in primary human and rat hepatocytes. Hepatology, 27 (6), 1687–1694.
   PubMed Web of Science ®Google Scholar
• Jacociunas, L.V., et al., 2013. Artichoke induces genetic toxicity in the cytokinesis-block micronucleus (CBMN) cytome assay. Food and Chemical Toxicology, 55, 56–59.
   PubMed Web of Science ®Google Scholar
• Joksić, G., et al., 2000. Influence of ribavirin on the micronucleus formation and in vitro proliferation of human lymphocytes. Neoplasma, 47 (5), 283–287.
   PubMed Web of Science ®Google Scholar
• Joksić, I., et al., 2006. Vitamin B12 reduces ribavirin-induced genotoxicity in phytohemaglutinin-stimulated human lymphocytes. The Tohoku Journal of Experimental Medicine, 209 (4), 347–354.
   PubMed Web of Science ®Google Scholar
• Kilham, L. and Ferm, V.H., 1977. Congenital anomalies induced in hamster embryos with ribavirin. Science, 195 (4276), 413–414.
   PubMed Web of Science ®Google Scholar
• Knasmüller, S., et al., 2004. Use of human-derived liver cell lines for the detection of environmental and dietary genotoxicants; current state of knowledge. Toxicology, 198 (1–3), 315–328.
   PubMed Web of Science ®Google Scholar
• Knasmüller, S., et al., 1998. Use of metabolically competent human hepatoma cells for the detection of mutagens and antimutagens. Mutation Research, 402 (1–2), 185–202.
   PubMed Web of Science ®Google Scholar
• Liang, T.J. and Ghany, M.G., 2013. Current and future therapies for hepatitis C virus infection. The New England Journal of Medicine, 368, 1907–1917.
   PubMed Web of Science ®Google Scholar
• Liu, W.L., et al., 2012. Ribavirin enhances the action of interferon-α against hepatitis C virus by promoting the p53 activity through the ERK1/2 pathway. PLoS One, 7 (9), e43824.
   PubMed Web of Science ®Google Scholar
• Loustaud-Ratti, V., et al., 2016. Ribavirin: past, present and future. World Journal of Hepatology, 8 (2), 123–130.
   PubMed Web of Science ®Google Scholar
• Narayana, K., et al., 2005. The antiviral drug ribavirin reversibly affects the reproductive parameters in the male Wistar rat. Folia Morphologica, 64 (2), 65–71.
   PubMedGoogle Scholar
• Narayana, K., D'Souza, U.J., and Rao, K.P., 1999. Possible reasons for spontaneous incidence of micronucleus in rodents. Indian Journal of Physiology and Pharmacology, 43 (4), 515–517.
   PubMedGoogle Scholar
• Narayana, K., D'Souza, U.J., and Seetharama Rao, K.P., 2002a. Ribavirin-induced sperm shape abnormalities in Wistar rat. Mutation Research, 513 (1–2), 193–196.
   PubMed Web of Science ®Google Scholar
• Narayana, K., D'Souza, U.J., and Seetharama Rao, K.P., 2002b. The genotoxic and cytotoxic effects of ribavirin in rat bone marrow. Mutation Research, 521 (1–2), 179–185.
   PubMed Web of Science ®Google Scholar
• Noshy, M.M., Hussien, N.A., and El-Ghor, A.A., 2013. Evaluation of the role of the antioxidant silymarin in modulating the in vivo genotoxicity of the antiviral drug ribavirin in mice. Mutation Research, 752 (1–2), 14–20.
   PubMed Web of Science ®Google Scholar
• OECD, 2016. Guidelines for the testing of chemicals. In vitro mammalian cell micronucleus test (487) [online]. Available from: http://www.oecd-ilibrary.org/environment/test-no-487-in-vitro-mammalian-cell-micronucleus-test_9789264264861-en [Accessed 09 September 2016].
   Google Scholar
• Seetharama Rao, K.P. and Narayana, K., 2005. In vivo chromosome damaging effects of an inosine monophosphate dehydrogenase inhibitor: ribavirin in mice. Indian Journal of Pharmacology, 37, 90–95.
   Google Scholar
• Sidwell, R.W., et al., 1972. Broad-spectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide. Science, 177, 705–706.
   PubMed Web of Science ®Google Scholar
• Steele, R.W., et al., 1988. Effects of ribavirin on neutrophil function. The American Journal of the Medical Sciences, 295 (6), 503–506.
   PubMed Web of Science ®Google Scholar
• Tatar, A., Özkurt, Z., and Kiki, I., 2005. Genotoxic effect of ribavirin in patients with Crimean-Congo hemorrhagic fever. Japanese Journal of Infectious Diseases, 58 (5), 313.
   PubMed Web of Science ®Google Scholar
• Tatar, A., et al., 2009. Evaluation of ribavirin genotoxicity with sister chromatid exchange and micronuclei assays in humans. Turkish Journal of Medical Science, 39 (2), 241–246.
   Web of Science ®Google Scholar
• Thomas, E., Ghany, M.G., and Liang, T.J., 2012. The application and mechanism of action of ribavirin in therapy of hepatitis C. Antiviral Chemistry & Chemotherapy, 23 (1), 1–12.
   PubMedGoogle Scholar
• Uhl, M., Helma, C., and Knasmüller, S., 1999. Single-cell gel electrophoresis assays with human-derived hepatoma (HepG2) cells. Mutation Research, 441 (2), 215–224.
   PubMed Web of Science ®Google Scholar
• Vallée, S., et al., 2000. Ribavirin-induced resistance to heat shock, inhibition of the Ras-Raf-1 pathway and arrest in G(1). European Journal of Pharmacology, 404 (1–2), 49–62.
   PubMed Web of Science ®Google Scholar
• Weiss, R.C., Cox, N.R., and Boudreaux, M.K., 1993. Toxicologic effects of ribavirin in cats. Journal of Veterinary Pharmacology and Therapeutics, 16 (3), 301–316.
   PubMed Web of Science ®Google Scholar